AI is spitting out more potential drugs than ever. This start-up wants to figure out which ones matter.
10x Science raises $4.8M to use AI for identifying promising drug candidates from vast molecular datasets.
Read on TechCrunch →Krafton, Naver, and Mirae Asset launch a $720 million fund for high-growth Indian startups, including those in AI and deeptech.
Why it matters
This significant investment from major global players into India's startup ecosystem, with a specific mention of AI and deeptech, signals strong confidence in the growth potential of Indian technology companies. It provides crucial capital for AI-focused startups to scale, innovate, and potentially become future technology leaders, contributing to India's position in the global AI landscape.
Big companies from South Korea are investing a lot of money into Indian startups. Some of this money will go to new companies that are building artificial intelligence (AI) and advanced technology.
10x Science raises $4.8M to use AI for identifying promising drug candidates from vast molecular datasets.
Read on TechCrunch →Google Cloud Next 2026 showcased numerous AI startups leveraging its cloud platform.
Read on TechCrunch →SpaceX is reportedly in talks to acquire AI coding startup Cursor, with an option to buy for $60 billion, highlighting the intense competition and strategic moves in the AI developer tools market.
Read on TechCrunch →